Skip to main navigation Skip to search Skip to main content

The relevance of persisters in tuberculosis drug discovery

  • Soma Mandal
  • , Samuel Njikan
  • , Anuradha Kumar
  • , Julie V. Early
  • , Tanya Parish
  • Infectious Disease Research Institute

Research output: Contribution to journalReview articlepeer-review

38 Citations (Scopus)

Abstract

Bacterial persisters are a subpopulation of cells that exhibit phenotypic resistance during exposure to a lethal dose of antibiotics. They are difficult to target and thought to contribute to the long treatment duration required for tuberculosis. Understanding the molecular and cellular biology of persisters is critical to finding new tuberculosis drugs that shorten treatment. This review focuses on mycobacterial persisters and describes the challenges they pose in tuberculosis therapy, their characteristics and formation, how persistence leads to resistance, and the current approaches being used to target persisters within mycobacterial drug discovery.

Original languageEnglish
Pages (from-to)492-499
Number of pages8
JournalMicrobiology (United Kingdom)
Volume165
Issue number5
DOIs
Publication statusPublished - 1 May 2019
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antibiotics
  • Drug discovery
  • Mycobacteria
  • Non-replicating organisms
  • Persistence
  • Tuberculosis

Fingerprint

Dive into the research topics of 'The relevance of persisters in tuberculosis drug discovery'. Together they form a unique fingerprint.

Cite this